Saponin-rich fraction from Agave sisalana: effect against malignant astrocytic cells and its chemical characterisation by ESI-MS/MS

Astrocytic tumour cells derived from human (GL-15) and rat (C6) gliomas, as well as non-tumoural astrocytic cells, were exposed to the saponin-rich fraction (SF) from Agave sisalana waste and the cytotoxic effects were evaluated. Cytotoxicity assays revealed a reduction of cell viability that was mo...

Full description

Saved in:
Bibliographic Details
Published in:Natural product research Vol. 33; no. 12; pp. 1769 - 1772
Main Authors: de Oliveira, João Victor A., Botura, Mariana B., dos Santos, Jener D. G., Argolo, Deivison S., da Silva, Victor Diogenes A., da Silva, Gisele D., de Lima, Hélimar G., Braz Filho, Raimundo, Vieira, Ivo Jose C., Branco, Alexsandro, Batatinha, Maria José M., Costa, Silvia L.
Format: Journal Article
Language:English
Published: England Taylor & Francis 18-06-2019
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Astrocytic tumour cells derived from human (GL-15) and rat (C6) gliomas, as well as non-tumoural astrocytic cells, were exposed to the saponin-rich fraction (SF) from Agave sisalana waste and the cytotoxic effects were evaluated. Cytotoxicity assays revealed a reduction of cell viability that was more intensive in glioma than in non-tumoural cells. The SF induced morphological changes in C6 cells. They were characterised by cytoplasmic vacuole formation associated with increase in the formation of acidic lysosomes. The SF was subjected to purification on Sephadex LH-20, which characterised three probable steroidal saponins (sisalins) by electrospray ionisation mass spectrometry multistage (ESI-MS n ). Sisalins from sisal may be responsible for the cytotoxicity, which involves cytoplasmatic vacuole formation and selective action for glioma cells.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Undefined-1
ObjectType-Feature-3
content type line 23
ISSN:1478-6419
1478-6427
DOI:10.1080/14786419.2018.1434633